FABP1 and breast cancer: In addition, FA synthase, a key enzyme of de novo lipogenesis that converts dietary carbohydrates to fatty acids, mediates EMT in breast cancer cells, possibly through regulating liver fatty acid-binding protein (L-FABP) and VEGF/VEGFR-2 [107,114].